DKK1 and biliary tract neoplasm: The combination of the anti-DKK1 antibody DKN-01 with nab-paclitaxel and gemcitabine did not show any benefit compared with nab-paclitaxel and gemcitabine alone in advanced biliary tract cancer [108].